Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19

BACKGROUND: Coronavirus disease 19 (COVID‐19)–associated coagulopathy is a hallmark of disease severity and poor prognosis. The key manifestations of this prothrombotic syndrome—microvascular thrombosis, stroke, and venous and pulmonary clots—are also observed in severe and catastrophic antiphosphol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollerbach, Anne, Müller‐Calleja, Nadine, Pedrosa, Denise, Canisius, Antje, Sprinzl, Martin F., Falter, Tanja, Rossmann, Heidi, Bodenstein, Marc, Werner, Christian, Sagoschen, Ingo, Münzel, Thomas, Schreiner, Oliver, Sivanathan, Visvakanth, Reuter, Michael, Niermann, Johannes, Galle, Peter R., Teyton, Luc, Ruf, Wolfram, Lackner, Karl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420426/
https://www.ncbi.nlm.nih.gov/pubmed/34242469
http://dx.doi.org/10.1111/jth.15455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420426/
https://www.ncbi.nlm.nih.gov/pubmed/34242469
http://dx.doi.org/10.1111/jth.15455

Ejemplares similares